Copyright of Content

The content on the Foxfire MedTech BV website (Foxfire-MedTech.com), including all text, images, graphics, and design elements, is protected by copyright laws and is the property of Foxfire MedTech BV. No portion of this content may be reproduced, republished, framed, or distributed in any way without prior written permission.

All visual and textual content on our Site, unless otherwise indicated, is either owned by Foxfire MedTech BV or licensed for our use. This includes all materials used for educational modules provided through subscriptions. Subscribers to our services are granted limited rights to download, use, and alter provided materials (e.g., templates, tools) strictly for personal or internal business purposes, subject to the terms of the applicable subscription.

We strive to respect copyright laws in all our dealings with employees, customers, vendors, and stakeholders. If you identify any content on our Site that you believe infringes on your copyright, please contact us. Upon verification, we will take appropriate action, including removing the material in question.

DMCA Notice

In accordance with the United States Digital Millennium Copyright Act (DMCA), we respond promptly to notices of alleged copyright infringement. To file a DMCA notice, please follow the procedure described by the U.S. Copyright Office at http://www.copyright.gov.

Upon receiving a valid DMCA notice, we may temporarily disable access to the alleged infringing material while we investigate. If infringement is confirmed, the material will be removed. If no infringement is found, access to the material will be restored.

Intellectual Property

The names, trademarks, logos, slogans, and service marks of Foxfire MedTech BV (including “Foxfire MedTech BV,” “Foxfire Academy,” and related marks) are the exclusive property of Foxfire MedTech BV. Unauthorized use of any of our trademarks or service marks is strictly prohibited without express written consent.

Questions or Concerns

If you have any questions or concerns regarding this statement, please contact us HERE, and we will respond promptly.